Talabostat in Treating Patients With Metastatic Kidney Cancer
Stopped safety reasons
Conditions
Interventions
- DRUG: talabostat mesylate
- BIOLOGICAL: enzyme inhibitor therapy
- DIAGNOSTIC_TEST: flow cytometry
- DIAGNOSTIC_TEST: laboratory biomarker analysis
- BIOLOGICAL: non-specific immune-modulator therapy
Sponsor
University of Nebraska